Rare disease at ASGCT 2027
May 3–7, 2027 Philadelphia, PA ~8k attendees Website
3 organizations at ASGCT 2027 present work in rare disease: 2 contract manufacturers, CROs and testing labs and 1 therapy developer. 3 of them have their own page in this guide. As of Oct 29, 2026.
Showing 1–3 of 3 organizations
| Organization | ASGCT 2027 Attendance |
|---|---|
Gene therapy developer and Bayer subsidiary building AAV treatments for Parkinson's disease, heart failure and other rare and common conditions. | Booth Exhibiting at Booth 422 |
Propria Branford, CT | |
Preclinical CRO testing therapies for inherited heart disease on engineered cardiac tissues made from human iPSC-derived heart muscle cells. | Booth Exhibiting at Booth 1512 |
PsychoGenics Paramus, NJ | |
Preclinical CRO for brain and rare disorders, offering validated mouse models, behavioral testing, EEG, electrophysiology and histology to measure treatment efficacy. | Booth Exhibiting at Booth 1017 |
Find buyers in rare disease
Tell us what you sell and we’ll find the people at organizations working on rare disease most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse ASGCT 2027 by
Organization type
Focus area
Exhibit hall
Everyone
Not affiliated with the American Society of Gene & Cell Therapy. Organization details are derived from ASGCT’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction